North America:
The North American topical corticosteroids market is highly developed, driven by the widespread prevalence of dermatological conditions such as eczema, psoriasis, and dermatitis. The United States leads the market, benefiting from advanced healthcare infrastructure, high awareness of skin health, and the availability of a wide range of topical corticosteroids. In...